0
Skip to Content
Mikaela Naylon Give Kids a Chance Act
One Pagers
Legislative History
Priority Review Vouchers
Combinations of Cancer Drugs
Climb the Hill
Sign up For Climb the Hill
Climb the Hill FAQ
Videos of KVC Kids
Kids' In Memoriam
Programs
Compassionate Use Navigator
Post Mortem Tissue Donation
Trial Eligibility
In the News
Articles - KVC in the News
Videos - KVC In the News
KVC Publications
About
Jacob
Mission/Leadership
Contact
Donate: check/DAF/stock
Donate: online
Open Menu
Close Menu
Mikaela Naylon Give Kids a Chance Act
One Pagers
Legislative History
Priority Review Vouchers
Combinations of Cancer Drugs
Climb the Hill
Sign up For Climb the Hill
Climb the Hill FAQ
Videos of KVC Kids
Kids' In Memoriam
Programs
Compassionate Use Navigator
Post Mortem Tissue Donation
Trial Eligibility
In the News
Articles - KVC in the News
Videos - KVC In the News
KVC Publications
About
Jacob
Mission/Leadership
Contact
Donate: check/DAF/stock
Donate: online
Open Menu
Close Menu
Folder:
Mikaela Naylon Give Kids a Chance Act
Back
One Pagers
Legislative History
Priority Review Vouchers
Combinations of Cancer Drugs
Folder:
Climb the Hill
Back
Sign up For Climb the Hill
Climb the Hill FAQ
Videos of KVC Kids
Kids' In Memoriam
Folder:
Programs
Back
Compassionate Use Navigator
Post Mortem Tissue Donation
Trial Eligibility
Folder:
In the News
Back
Articles - KVC in the News
Videos - KVC In the News
KVC Publications
Folder:
About
Back
Jacob
Mission/Leadership
Contact
Donate: check/DAF/stock
Donate: online
Mikaela Naylon. Remarks at FDA Osteosarcoma Institute Meeting, October 10, 2025
